28 June 2024
Latham Advises Coherus BioSciences in US$40 Million Divestment
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jekkie Kim Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Ben Potter Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Josh Dubofsky Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Danny Nordstrom | Latham & Watkins LLP | Associate | corporate | Not stated |
| Alex Bogdon | Latham & Watkins LLP | Associate | corporate | Not stated |
| Fiona Gillan | Latham & Watkins LLP | Associate | healthcare and life sciences | Not stated |
| Mizuna Sekine | Latham & Watkins LLP | Associate | healthcare and life sciences | Not stated |
| Patrick Chew | Latham & Watkins LLP | Associate | healthcare and life sciences | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Dennis Poehland | Latham & Watkins LLP | Associate | tax | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Bay Area |
| Philip Stoup | Latham & Watkins LLP | Partner | securities | Bay Area |
| Tess Bloom | Latham & Watkins LLP | Associate | securities | Not stated |
10 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 40m (US$40 million)
- What the figure measures
- Total transaction value
- Client
- Coherus BioSciences, Inc.Sell-side
- Counterparties
- Hong Kong King-Friend Industrial Co. Ltd. (Buy-side)